Samantha Semenkow

Sep 04, 2026

Samantha Semenkow rated DNTH as Buy on Sep 04, 2026, setting a price target of 156. Shares have remained stable near 107.85, leaving the 156 target still in play.

Aug 05, 2026

On Aug 05, 2026, RYTM was given a Buy rating by Samantha Semenkow, with a target price of 143. Despite the Buy call, shares fell from 104.89 to 104.89, challenging the optimistic stance.

Jul 31, 2026

WVE received a Buy rating from Samantha Semenkow on Jul 31, 2026, aiming for 19. The rating hasn’t played out as hoped, with the stock trading 14.70% below expectations.

Jul 31, 2026

On Jul 31, 2026, Samantha Semenkow published a Buy outlook on AGIO, with a target of 52. Shares gained 10.36%, underscoring the accuracy of the bullish outlook toward 52.

Jul 21, 2026

Samantha Semenkow on Jul 21, 2026 assigned ARGX a Buy rating, with a price target of 1182. The Buy call aligned well with market performance, producing a gain of 20.43%.

Jun 30, 2026

On Jun 30, 2026, Samantha Semenkow reaffirmed IMVT with a Buy rating, targeting 61. Market indecision has kept the 61 target in a holding pattern.

May 22, 2026

SABS was rated Buy by Samantha Semenkow on May 22, 2026, with a price objective of 11. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

May 22, 2026

On May 22, 2026, Samantha Semenkow initiated coverage on SNSE with a Buy rating and target of 55. The Buy call has yet to be validated as shares remain 41.15 away from the target.

May 21, 2026

Samantha Semenkow issued a Buy recommendation for ROIV on May 21, 2026, price target set at 42. Investors following the Buy call captured upside momentum, with shares now at 34.41.

May 06, 2026

Samantha Semenkow rated SYRE as Buy on May 06, 2026, setting a price target of 97. The call has proven timely, with shares rising 19.52% toward the price target of 97.

Apr 21, 2026

On Apr 21, 2026, NKTR was given a Buy rating by Samantha Semenkow, with a target price of 151. Despite the Buy call, shares fell from 76.37 to 76.37, challenging the optimistic stance.

Apr 02, 2026

BHVN received a Buy rating from Samantha Semenkow on Apr 02, 2026, aiming for 17. Momentum has favored the Buy call, with shares climbing from 15.86 to 15.86, rewarding those who trusted the recommendation.

Mar 26, 2026

On Mar 26, 2026, Samantha Semenkow published a Buy outlook on BEAM, with a target of 68. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 29.46.

Mar 10, 2026

Samantha Semenkow on Mar 10, 2026 assigned BIOA a Buy rating, with a price target of 52. The call has struggled to gain traction, with shares losing 54.70%.

Feb 25, 2026

On Feb 25, 2026, Samantha Semenkow reaffirmed LRMR with a Buy rating, targeting 14. Shares slid 35.63% despite the recommendation, highlighting downside risks.

Feb 17, 2026

CGEM was rated Buy by Samantha Semenkow on Feb 17, 2026, with a price objective of 33. A bullish response from the market helped close the gap of 10.84 to the target.

Dec 09, 2025

Samantha Semenkow issued a Buy recommendation for GPCR on Dec 09, 2025, price target set at 100. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Dec 02, 2024

VYGR received a Buy rating from Samantha Semenkow on Dec 02, 2024, aiming for 12. The rating hasn’t played out as hoped, with the stock trading 51.23% below expectations.

May 09, 2024

On May 09, 2024, Samantha Semenkow published a Buy outlook on EDIT, with a target of 15. Market action contradicted the Buy thesis, as shares slipped to 3.08.